Keep below -20°C for up to 1 year. Avoid repeated freeze-and-thaw. For short term storage (< 3 weeks) keep at 4°C.
Introduction
Ceftazidime (INN) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections. Ceftazidime pentahydrate is marketed under various trade names including Cefzim (Pharco B International), Fortum (GSK), and Fortaz.
Antigen Description
The ceftazidime hydrate and KLH (keyhole limpet hemocyanin) (10 mg each) are conjugated by EDC method in 0.1 M MES pH 5.0. The carboxyl group in the ceftazidime is directly linked to an amine group in the KLH, and/or a carboxyl group in the KLH is directly linked to the amine group in the ceftazidime, without any linker by EDC conjugation method. Given the molecular weights of ceftazidime hydrate and KLH are 546.58 Da and 8,000 – 9,000 kDa, respectively, the molar ratio of ceftazidime:KLH in the conjugation solution is 14636 - 16466:1. The resultant conjugation solution is then buffer-exchanged with 20 mM PBS, pH 7.4. The number of ceftazidime that is actually conjugated to each KLH molecule is not determined.
Note: Due to its high molecular weight and its tendency to form aggregates, the conjugate is not completely soluble in the buffer that it is in. Therefore, it is strongly recommended to vigorously vortex immediately prior to aliquot or use.
Payment methods we support:
Invoice / Purchase Order
Credit card
My Review for Ceftazidime [KLH]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.